These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2949023)

  • 1. Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial.
    Sacks SL; Portnoy J; Lawee D; Schlech W; Aoki FY; Tyrrell DL; Poisson M; Bright C; Kaluski J
    J Infect Dis; 1987 Feb; 155(2):178-86. PubMed ID: 2949023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study.
    Barton SE; Munday PE; Kinghorn GR; van der Meijden WI; Stolz E; Notowicz A; Rashid S; Schuller JL; Essex-Cater AJ; Kuijpers MH
    Genitourin Med; 1986 Aug; 62(4):247-50. PubMed ID: 2942457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foscarnet (phosphonoformate sodium) in the treatment of recurrent male genital herpes.
    Lim KB; Doraisingham S; Thirumoorthy T; Lee CT; Ling AE; Tan T
    Ann Acad Med Singap; 1986 Oct; 15(4):617-22. PubMed ID: 2952046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of recurrent genital herpes infections with foscarnet.
    Wallin J; Lernestedt JO; Ogenstad S; Lycke E
    Scand J Infect Dis; 1985; 17(2):165-72. PubMed ID: 3161176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
    N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs.
    Mayo DR; Lucia HL; Hsiung GD
    Intervirology; 1983; 19(1):26-32. PubMed ID: 6298142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study Group.
    Sacks SL; Tyrrell LD; Lawee D; Schlech W; Gill MJ; Aoki FY; Martel AY; Singer J
    J Infect Dis; 1991 Oct; 164(4):665-72. PubMed ID: 1894930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes.
    Douglas JM; Judson FN; Levin MJ; Bosso JA; Spruance SL; Johnston JM; Corey L; McMillan JA; Weiner LB; Frank JA
    Antimicrob Agents Chemother; 1986 Mar; 29(3):464-7. PubMed ID: 3521487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy.
    Rachlis AR
    Clin Dermatol; 1989; 7(3):69-79. PubMed ID: 2478279
    [No Abstract]   [Full Text] [Related]  

  • 14. Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A
    Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genivir (DIP-253) 1% cream versus placebo cream in the treatment of recurrent genital herpes: a double-blind study.
    Lassus A; Dahlgren A; Linnavuori K
    Int J STD AIDS; 1990 Jan; 1(1):18-20. PubMed ID: 2099194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.